Icon
+91 94997 68112
Login Register

Argatroban in Sodium Chloride - (50mg/50ml; Injectable, Intravenous)

Argatroban Eagle
50mg/50ml; Injectable, Intravenous
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Prophylaxis and treatment of thrombosis in heparin-induced thrombocytopenia (HIT) or in those with or at risk of HIT undergoing percutaneous coronary intervention (PCI).
Yes
****** ** *** ***** ** **** **** ** **** ******* '*** (**** **, ****); '*** (**** **, ****) *** *** ************ *********. ******* *** ********** *** ********* **** ****** ***** ********* ** *** ********** ****** ******** *** ******* ** ** ** *** ****. ** ***** ******* *** ***** **** ** **** ****. ** ***** ******* *** ** ******** ** ****. **** ******* **** ** ** *********** *** *** ******* **** ******* ******** ** **** ****. ****** *** *** ***** ******** ** *** **, ****. ***** ********* ******* ***** *** ****** **** *********** ***** ** ***** **, ****.
Argatroban in Sodium Chloride Patent 1 Patent 2
****** ******* *******
****** (*****) ******* *******
****** ***** ************ ***(*)(*) ***(*)(*)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** **** **, **** ******* **** ** *** *, **** ** **
****** (*****) ** \ ** **** **, **** ******* **** ***** **** ****(***** ******)
  1. *** **, **** : ****** ******** ***** ***** *** **** ** **** ******* '*** (**** **, ****), '*** (**** **, ****).
  2. *** **, **** : ***** ***** * **** ******* ****** ** ****** ***** **** ** **** ******* '*** (**** **, ****), '*** (**** **, ****).
  3. *** **, **** : ****** *** ***** ******* * **********, *** ***** ** ***** *** *** *****.
  4. *** *, **** : ****** ******** *** ******* ** ********** *******.
  5. *** **, **** : ****** ******** ***** ***** *** **** ** **** ******* '*** (**** **, ****), '*** (**** **, ****).
  6. *** **, **** : ***** ***** * **** ******* ****** ** *** *******.
  7. *** **, **** : ********** ********* **** ******(*****)
  8. *** *, **** : ********** ******* **** *** *** ********* ****** ******** *********, ** **/** ** ** * *************** ********** **** ** ‘**’ ****** ** *** *** ********** ** ****** ******** *********, ** **/** **

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.